2021 annual financial data
REGENXBIO 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was 46.53%.
Operating income was 159,980,000 USD and net income was 127,840,000 USD.
Operating cash flow was 218,875,000 USD.
Get free REGENXBIO email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 470,347,000 USD
- Operating income
- 159,980,000 USD
- Net income
- 127,840,000 USD
- Operating cash flow
- 218,875,000 USD